Abstract
5-Hydroxytryptamine (5-HT, 5-160 microgram kg-1) injected intravenously in pentobarbitone-anaesthetized, open-chest cats caused dose-dependent increases in pulmonary arterial and intratracheal pressures. There was also a marked systemic hypotension and bradycardia. The pulmonary effects were completely prevented by ketanserin (0.2 mg kg-1), a selective 5-HT2 blocking drug. Ketanserin (0.2 mg kg-1) itself lowered arterial pressure (by 30-40 mmHg) but this systemic hypotension was relatively transient. Endotoxin (E. coli) administration resulted in pulmonary hypertension, increases in intratracheal pressure and airways resistance and reductions in lung compliance and in arterial PO2. Only the airways resistance response was modified by ketanserin (0.2 mg kg-1), suggesting a relatively unimportant role for 5-HT in mediating the acute, pulmonary effects of endotoxin in this species. The reductions in arterial (mixed venous) pH and in PO2 that resulted from endotoxin administration were not affected by pretreatment with ketanserin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson F. L., Tsagaris T. J., Jubiz W., Kuida H. Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol. 1975 May;228(5):1479–1482. doi: 10.1152/ajplegacy.1975.228.5.1479. [DOI] [PubMed] [Google Scholar]
- Fletcher J. R., Ramwell P. W., Harris R. H. Thromboxane, prostacyclin, and hemodynamic events in primate endotoxin shock. Adv Shock Res. 1981;5:143–148. [PubMed] [Google Scholar]
- Frölich J. C., Ogletree M., Peskar B. A., Brigham K. L. Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res. 1980;7:745–750. [PubMed] [Google Scholar]
- Parratt J. R. Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol. 1973 Jan;47(1):12–25. doi: 10.1111/j.1476-5381.1973.tb08154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parratt J. R., Sturgess R. M. The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat. Br J Pharmacol. 1976 Dec;58(4):547–551. doi: 10.1111/j.1476-5381.1976.tb08622.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parratt J. R., Sturgess R. M. The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol. 1977 Jun;60(2):209–219. doi: 10.1111/j.1476-5381.1977.tb07743.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Nueten J. M., Janssen P. A., Van Beek J., Xhonneux R., Verbeuren T. J., Vanhoutte P. M. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther. 1981 Jul;218(1):217–230. [PubMed] [Google Scholar]